Skip to main content

Table 3 IHC characterisations in the 15 cases of Ewing-like sarcoma and 15 cases of negative controls

From: Detection of BCOR gene rearrangement in Ewing-like sarcoma: an important diagnostic tool

 

CD99

Fli-1

CCNB3

BCOR

DUX4

Nkx2.2

WT-1

calretinin

MUC4

TLE1

EMA

ELS

13/15 (87%)

6/15 (40%)

0

0

1/12 (8%)

5/15 (33%)

1/11 (9%)

3/10 (30%)

1/10 (10%)

9/15 (60%)

5/11 (45%)

ES

7/7 (100%)

5/7 (71%)

0

0

0

7/7 (100%)

0

0

0

3/7 (43%)

0

SS

3/5 (60%)

3/5 (60%)

0

3/5 (60%)

1/5 (20%)

3/5 (60%)

0

0

0

4/5 (80%)

2/3 (67%)

MPNST

2/2 (100%)

2/2 (100%)

0

2/2 (100%)

0

1/2 (50%)

0

1/10

0

2/2 (100%)

0

OS

1/1 (100%)

1/1 (100%)

1/1 (100%)

1/1 (100%)

0

0

0

0

0

1/1 (100%)

0

  1. ELS Ewing-like sarcoma, ES Ewing sarcoma, SS synovial sarcoma, MPNST malignant peripheral nerve sheath tumor, OS osteosarcoma